Your browser doesn't support javascript.
loading
The identification of CCL18 as biomarker of disease activity in localized scleroderma.
Mertens, J S; de Jong, E M G J; van den Hoogen, L L; Wienke, J; Thurlings, R M; Seyger, M M B; Hoppenreijs, E P A H; Wijngaarde, C A; van Vlijmen-Willems, I M J J; van den Bogaard, E; Giovannone, B; van Wijk, F; van Royen-Kerkhof, A; Marut, W; Radstake, T R D.
Afiliación
  • Mertens JS; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherland
  • de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands; Radboud University, Nijmegen, the Netherlands.
  • van den Hoogen LL; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Wienke J; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Thurlings RM; Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Seyger MMB; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Hoppenreijs EPAH; Department of Paediatric Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Wijngaarde CA; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, the Netherlands.
  • van Vlijmen-Willems IMJJ; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • van den Bogaard E; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Giovannone B; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • van Wijk F; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • van Royen-Kerkhof A; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Marut W; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Radstake TRD; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands; Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
J Autoimmun ; 101: 86-93, 2019 07.
Article en En | MEDLINE | ID: mdl-31006523
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Biomarcadores / Quimiocinas CC Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Autoimmun Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Biomarcadores / Quimiocinas CC Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Autoimmun Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido